CXCL8 and COVID-19: Clinical evidence suggests that patients with severe COVID-19 have markedly increased levels of pro-inflammatory cytokines within their bodies, including IL-1β, IL-2, IL-6, IL-7, IL8, TNF-α, CCL2, MIP-1α, and CXCL10 [2, 45, 46].